Cryo-Cell International, Inc. CCEL

CCEL Company Overview

Cryo-Cell International, Inc. is a U.S.-based biocellular preservation company focused on the collection, processing, and long-term storage of umbilical cord blood and cord tissue stem cells. The company operates within the regenerative medicine, biotechnology services, and healthcare storage industries, serving expectant parents, healthcare providers, and emerging cell-therapy markets. Its primary revenue drivers are stem cell banking services, including upfront processing fees and recurring annual storage fees associated with preserved cord blood and tissue samples.

The company was founded in 1989 and is headquartered in Oldsmar, Florida. Cryo-Cell was among the early commercial entrants in private cord blood banking in the United States and has positioned itself around proprietary preservation technologies, long-term specimen storage infrastructure, and quality-control standards. The company markets the potential future therapeutic applications of newborn stem cells in regenerative medicine and immune-related treatments, although many clinical applications remain under ongoing medical and regulatory evaluation.